Results 51 to 60 of about 11,698 (215)

Rhabdomyolysis as first presentation of the Conn’s syndrome: a clinical case

Arterial Hypertension
Primary hyperaldosteronism is the leading cause of secondary hypertension, often presented with hypokalemia and even rare with its consequences. We describe a case of a 62-year-old man admitted to the emergency department with rhabdomyolysis from severe ...
Irida Kecaj, Ergita Nelaj, Ilir Gjermeni, Arben Gjata, Kei Xhixhabesi, Irda Rrugeja, Ina Refatllari, Margarita Gjata   +7 more
doaj   +1 more source

Primary Hyperaldosteronism: When to Suspect It and How to Confirm Its Diagnosis

Endocrines, 2022
The definition of primary hyperaldosteronism (PA) has shifted, as progress has been made in understanding the disease. PA can be produced by unilateral or bilateral cortical adrenal hyperproduction of aldosterone, due to hyperplasia, aldosterone ...
Jorge Gabriel Ruiz-Sánchez, Mario Pazos Guerra, Diego Meneses, Isabelle Runkle   +3 more
doaj   +1 more source

Improving primary aldosteronism diagnosis and treatment: outcomes from an endocrine hypertension service

Internal Medicine Journal, EarlyView.
Abstract Aims To evaluate the sustained impact of the Endocrine Hypertension Service on primary aldosteronism (PA) diagnosis and management over a subsequent 3‐year period. Background PA is a prevalent yet underdiagnosed cause of secondary hypertension, associated with increased cardiovascular, renal and metabolic risk. Limited awareness, resources and
Minn W. Chow, Chrislyn Ng, Jimmy Shen, Peter J. Fuller, Jun Yang, Renata Libianto   +5 more
wiley   +1 more source

A scoping review of specialist hypertension clinics

Internal Medicine Journal, EarlyView.
Abstract Background Hypertension is an important preventable risk factor for cardiovascular and kidney disease, with limited data regarding the impact on blood pressure (BP) control following management in specialist hypertension clinics globally. Aims To summarise current literature on BP outcomes in SHCs and identify gaps in evidence.
Destiny O'Dea, Andrew Siyoung Chung, Arunima Jain, Amy Kang, Zoltan Endre, Sradha Kotwal   +5 more
wiley   +1 more source

Associations of finerenone with reduced insulin resistance in patients with type 2 diabetes and chronic kidney disease: A real‐world observational study

Journal of Diabetes Investigation, EarlyView.
This real‐world observational study enrolled 256 patients with type 2 diabetes and chronic kidney disease (T2D‐CKD). After 12 months of finerenone treatment, 45 patients completed follow‐up. Finerenone was associated with significant improvements in insulin resistance markers (HOMA‐IR, TyG index), lipid profile (LDL‐C), glycemic control (HbA1c), and ...
Xin Zhao, Bohan Liu, Ran Sun, Yaxuan Shi, Ya Liu   +4 more
wiley   +1 more source

Secondary hypertension as a cause of treatment resistance

Blood Pressure, 2023
In secondary hypertension, elevated blood pressure is caused by a known and/or potentially treatable underlying disease. Although the prevalence of secondary hypertension depends on the patient population and the thoroughness of applied diagnostic ...
Isabella Sudano, Paolo Suter, Felix Beuschlein   +2 more
doaj   +1 more source

Diagnosis and treatment of primary hyperaldosteronism: Review [PDF]

, 2007
Primary hyperaldosteronism is the syndrome of excessive aldosterone secretion and concomitant suppression of the angiotensin-renin system. Its main pathophysiological features are hypertension, altered potassium homeostasis and accelerated target organ ...
Oezmen, Dilek, Oezmen, Bilgin
core  

Giant Adrenal Oncocytoma: A Case Report and Literature Review

IJU Case Reports, Volume 9, Issue 5, September 2026.
ABSTRACT Introduction Adrenal oncocytomas are rare, nonfunctioning tumors composed of eosinophilic oncocytic cells whose nonspecific imaging often impedes preoperative diagnosis. We report a case of a large nonfunctioning adrenal oncocytoma with borderline malignant potential, incidentally discovered during cardiac symptom evaluation.
Kohei Yamakawa, Akihiro Ono, Ryo Amakawa, Hirotomo Koda, Ryohei Nishimoto, Yasushi Inoue, Teppei Morikawa, Masashi Kusakabe, Haruki Kume, Masaki Nakamura   +9 more
wiley   +1 more source

Risk of severe erectile dysfunction in primary hyperaldosteronism: A population-based propensity score matching cohort study [PDF]

, 2019
[[abstract]]Background: An elevated plasma aldosterone level has been reported as an independent risk factor for severe erectile dysfunction in men. The aim of this study was to explore whether primary hyperaldosteronism patients experience erectile ...
Chang, CH;Chueh, SCJ;Wu, VC;Chen, L;Lin, YH;Hu, YH;Wu, KD;Tsai, YC
core   +1 more source

Liquid Chromatography-Tandem Mass Spectrometry Outperforms Radioimmunoassay in Guiding Surgical Decisions Based on Adrenal Venous Sampling in Primary Aldosteronism [PDF]

Endocrinology and Metabolism
Background Adrenal venous sampling (AVS) is essential for diagnosing unilateral aldosterone oversecretion in primary aldosteronism (PA). Traditionally, AVS relies on radioimmunoassay (RIA) to measure plasma aldosterone concentration (PAC), although RIA ...
Bo-Ching Lee, Chien-Wei Huang, Chin-Chen Chang, Guan-Yuan Chen, Jia-Zheng Huang, Pin-Chen Chen, Te-I Weng, Kao-Lang Liu, Vin-Cent Wu, Yen-Hung Lin,   +10 more
doaj   +1 more source